Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.17%
#3 Velvet Velvet +37.34%
#4 Black Phoenix Black Phoenix +34.06%
#5 Akedo Akedo +29.10%
#6 Cross Cross +27.01%
#7 Cap Cap +18.79%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.46%
#9 QANplatform QANplatform +14.35%
#10 Bitway Bitway +13.02%
Coin of the day
Glidr Glidr
設定
言語
日本
通貨
USD
テーマ
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
株式のランク #39104
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
株価
$0.02243487
最終同期: 2025-06-04
時価総額
$650.09K
変化（1日）
0.39%
変化（1年）
0.00%
国
SE
取引 Lipidor AB (publ) (LIPI)

カテゴリー

Healthcare
Lipidor AB (publ)（LIPI）のP/S比率
August 2026 時点のP/S比率 TTM: 12.49K
Lipidor AB (publ) の最新の財務報告および株価によると、現在のP/S比率（TTM）は 12.49K です。2023 年末時点でのP/S比率は 187.24 でした。
Lipidor AB (publ) の P/S 比率の履歴（2016 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 12.49K 89.82%
2024 6.58K 3,414.61%
2023 187.24 -60.49%
2022 473.93 2,985.50%
2021 15.36 -97.13%
2020 534.79 -88.42%
2019 4.62K 822.07%
2018 501.03 35.80%
2017 368.94 -14.60%
2016 432.02 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 -99.88%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 -99.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 -99.94%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -99.96%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 -99.96%
US